AAIC

AAIC 2023 – Acumen’s new amyloid approach impresses
EP Vantage
Wed, 07/19/23 - 10:15 am
AAIC
Acumen
Alzheimer's disease
ACU193
AAIC: First Clinical Data from an RNAi Therapeutic for Alzheimer’s Continue to Impress
BioSpace
Tue, 07/18/23 - 11:55 am
AAIC
Alnylam
RNAi
Alzheimer's disease
ALN-APP
clinical trials
As Eisai, Biogen plot a course to accelerated approvals for Alzheimer’s drug, a mob of skeptics are waiting to decipher hard numbers
Endpoints
Tue, 07/24/18 - 11:30 am
Eisai
Biogen
Alzheimer's disease
BAN2401
AAIC
AAIC Is Coming: Here's What To Expect, Biogen And Eli Lilly Investors
Yahoo/Benzinga
Sun, 07/5/15 - 10:57 am
AAIC
Biogen
Eli Lilly
aducanumab
solanezumab